A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients
- PMID: 18513271
- DOI: 10.1111/j.1572-0241.2007.01780.x
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients
Abstract
Background: We sought to determine nationwide, population-based trends in rates of Clostridium difficile (C. difficile) infection among hospitalized inflammatory bowel disease (IBD) patients in the United States, and to determine its mortality and economic impact.
Methods: We analyzed discharge records from the Nationwide Inpatient Sample, and used the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes to identify Crohn's disease (CD) and ulcerative colitis (UC) cases, and cases of C. difficile infection between 1998 and 2004. Temporal patterns of C. difficile incidence in IBD patients were compared to non-IBD gastroenterology patients and all-hospitalized patients. The impact of C. difficile on in-hospital mortality and resource utilization was quantified using multiple regression analysis.
Results: The prevalence of C. difficile among UC patients (37.3 per 1,000, 95% confidence interval [CI] 34.0-40.7 per 1,000) was higher than that among CD patients (10.9 per 1,000, 95% CI 9.9-12.0 per 1,000), non-IBD gastrointestinal (GI) patients (4.8 per 1,000, 95% CI 4.6-5.0 per 1,000), and general medical patients (4.5 per 1,000, 95% CI 4.2-4.7 per 1,000). C. difficile incidence nearly doubled among UC patients (26.6 per 1,000 to 51.2 per 1,000) over 7 yr. After adjustment for confounders, C. difficile infection was associated with greater mortality among patients with UC (odds ratio [OR] 3.79, 95% CI 2.84-5.06), but not CD (OR 1.66, 95% CI 0.75-3.66). C. difficile was also associated with 65% and 46% longer lengths of stay, which correlated with 63% and 46% higher average hospital charges, for CD and UC patients, respectively.
Conclusions: C. difficile infection is a growing public health issue among hospitalized IBD patients, especially those with UC, and is associated with higher mortality and resource utilization, prompting the need for better preventative measures and early detection.
Comment in
-
More bad news on Clostridium difficile in inflammatory bowel disease.Inflamm Bowel Dis. 2009 Apr;15(4):641-2. doi: 10.1002/ibd.20751. Inflamm Bowel Dis. 2009. PMID: 18785624 No abstract available.
Similar articles
-
Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.Am J Gastroenterol. 2008 Sep;103(9):2272-80. doi: 10.1111/j.1572-0241.2008.02052.x. Epub 2008 Aug 5. Am J Gastroenterol. 2008. PMID: 18684186
-
Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.Gut. 2008 Feb;57(2):205-10. doi: 10.1136/gut.2007.128231. Epub 2007 Sep 28. Gut. 2008. PMID: 17905821
-
Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.Digestion. 2011;84(3):187-92. doi: 10.1159/000324617. Epub 2011 Jun 1. Digestion. 2011. PMID: 21646782
-
Clostridium difficile and inflammatory bowel disease.Gastroenterol Clin North Am. 2009 Dec;38(4):711-28. doi: 10.1016/j.gtc.2009.07.003. Gastroenterol Clin North Am. 2009. PMID: 19913210 Review.
-
The evolving epidemiology of inflammatory bowel disease.Curr Opin Gastroenterol. 2009 Jul;25(4):301-5. doi: 10.1097/MOG.0b013e32832b12ef. Curr Opin Gastroenterol. 2009. PMID: 19349861 Review.
Cited by
-
Current Management of Acute Severe Ulcerative Colitis: New Insights on the Surgical Approaches.J Pers Med. 2024 May 28;14(6):580. doi: 10.3390/jpm14060580. J Pers Med. 2024. PMID: 38929801 Free PMC article. Review.
-
Testing and Diagnosis of Clostridioides difficile Infection in Special Scenarios: A Systematic Review.Cureus. 2024 Apr 25;16(4):e59016. doi: 10.7759/cureus.59016. eCollection 2024 Apr. Cureus. 2024. PMID: 38800338 Free PMC article. Review.
-
Treatment endpoints in ulcerative colitis: Does one size fit all?World J Gastrointest Pharmacol Ther. 2024 May 5;15(2):91591. doi: 10.4292/wjgpt.v15.i2.91591. World J Gastrointest Pharmacol Ther. 2024. PMID: 38764502 Free PMC article.
-
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29. Clin Microbiol Rev. 2024. PMID: 38421181 Review.
-
Modern practical management of acute severe colitis.Indian J Gastroenterol. 2024 Feb;43(1):78-92. doi: 10.1007/s12664-024-01522-4. Epub 2024 Feb 26. Indian J Gastroenterol. 2024. PMID: 38407787 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
